C57BL/6JCya-Umodem1flox/Cya
Common Name:
Umod-flox
Product ID:
S-CKO-06540
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Umod-flox
Strain ID
CKOCMP-22242-Umod-B6J-VA
Gene Name
Product ID
S-CKO-06540
Gene Alias
THP; Urehd1; urehr4
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
7
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Umodem1flox/Cya mice (Catalog S-CKO-06540) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000033263
NCBI RefSeq
NM_009470
Target Region
Exon 2~4
Size of Effective Region
~2.5 kb
Detailed Document
Overview of Gene Research
Umod, which codes for uromodulin (also known as Tamm-Horsfall protein), is a kidney-specific gene. Uromodulin is the most abundant protein excreted in normal urine and has important functions in the kidney and urine [5,6]. The gene is associated with pathways related to kidney function and diseases. Studying genetic variations in Umod can provide insights into the pathogenesis and prognosis of kidney-related disorders [1,5].
Rare mutations in Umod are the major cause of autosomal dominant tubulointerstitial kidney disease (ADTKD), which leads to chronic kidney disease (CKD) and end-stage renal disease (ESRD) [3,4,5,7]. In ADTKD-UMOD patients, there are distinct clinical features such as hyperuricemia, gout, and progressive CKD [2,4]. A novel heterozygous Umod mutation was found in a Chinese pediatric case of ADTKD-UMOD, expanding the understanding of the mutation spectrum and phenotype in children [4]. Also, an intermediate-effect Umod variant (p.Thr62Pro) was identified, which confers risk for CKD, showing reduced disease severity compared to canonical ADTKD mutations [6].
In conclusion, Umod is crucial for normal kidney function, and its mutations are significantly associated with ADTKD and CKD. The study of Umod, especially through genetic models, helps in understanding the pathogenesis and prognosis of these kidney diseases, potentially guiding future diagnostic and therapeutic strategies.
References:
1. Devuyst, Olivier, Bochud, Murielle, Olinger, Eric. 2022. UMOD and the architecture of kidney disease. In Pflugers Archiv : European journal of physiology, 474, 771-781. doi:10.1007/s00424-022-02733-4. https://pubmed.ncbi.nlm.nih.gov/35881244/
2. Mabillard, Holly, Olinger, Eric, Sayer, John A. 2022. UMOD and you! Explaining a rare disease diagnosis. In Journal of rare diseases (Berlin, Germany), 1, 4. doi:10.1007/s44162-022-00005-4. https://pubmed.ncbi.nlm.nih.gov/36569465/
3. Olinger, Eric, Hofmann, Patrick, Kidd, Kendrah, Bleyer, Anthony J, Devuyst, Olivier. 2020. Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1. In Kidney international, 98, 717-731. doi:10.1016/j.kint.2020.04.038. https://pubmed.ncbi.nlm.nih.gov/32450155/
4. Yang, Jing, Zhang, Yu, Zhou, Jianhua. 2019. UMOD gene mutations in Chinese patients with autosomal dominant tubulointerstitial kidney disease: a pediatric case report and literature review. In BMC pediatrics, 19, 145. doi:10.1186/s12887-019-1522-7. https://pubmed.ncbi.nlm.nih.gov/31068150/
5. Devuyst, Olivier, Pattaro, Cristian. 2017. The UMOD Locus: Insights into the Pathogenesis and Prognosis of Kidney Disease. In Journal of the American Society of Nephrology : JASN, 29, 713-726. doi:10.1681/ASN.2017070716. https://pubmed.ncbi.nlm.nih.gov/29180396/
6. Olinger, Eric, Schaeffer, Céline, Kidd, Kendrah, Rampoldi, Luca, Devuyst, Olivier. 2022. An intermediate-effect size variant in UMOD confers risk for chronic kidney disease. In Proceedings of the National Academy of Sciences of the United States of America, 119, e2114734119. doi:10.1073/pnas.2114734119. https://pubmed.ncbi.nlm.nih.gov/35947615/
7. Chen, Huan-Da, Yu, Chih-Chuan, Yang, I-Hsiao, Chang, Jer-Ming, Hwang, Daw-Yang. 2022. UMOD Mutations in Chronic Kidney Disease in Taiwan. In Biomedicines, 10, . doi:10.3390/biomedicines10092265. https://pubmed.ncbi.nlm.nih.gov/36140366/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen